Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators
Background and Aim Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack. Methods A total of 1097 UGIB attacks in 690 patien...
Gespeichert in:
Veröffentlicht in: | Journal of gastroenterology and hepatology 2019-09, Vol.34 (9), p.1604-1610 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1610 |
---|---|
container_issue | 9 |
container_start_page | 1604 |
container_title | Journal of gastroenterology and hepatology |
container_volume | 34 |
creator | Fouad, Tamer R Abdelsameea, Eman Abdel‐Razek, Wael Attia, Ahmed Mohamed, Anwar Metwally, Khaled Naguib, Mary Waked, Imam |
description | Background and Aim
Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack.
Methods
A total of 1097 UGIB attacks in 690 patients with liver cirrhosis were studied. Their clinical, laboratory, and endoscopic data were reviewed.
Results
Mean age 53.2 ± 10.6 (20–90) years, 78% men and the main cause of liver disease was hepatitis C (94.9%). Complications occurred after 467 attacks (42.6%): hepatic encephalopathy 31.4%, spontaneous bacterial peritonitis 18%, renal impairment 13.2%, and re‐bleeding in 7.8%, while 199 patients (18.1%) died. Complications followed 78.4% of bleeding from gastric varices, 75% of post‐interventional ulcers, 10.8% of peptic ulcers, and 5.9% of telangiectasias. By univariate analysis: packed red blood cells units transfused, transaminases, Child–Pugh (CP), model of end‐stage liver disease (MELD), and albumin–bilirubin (ALBI) scores, beside the presence of hepatocellular carcinoma (HCC), previous hemorrhage in the previous 6 months, and the source of bleeding, were associated with occurrence of complications. By multivariate analysis, independent predictors of complications were CP, MELD, and ALBI scores (odds ratio, 95% confidence interval: 5.63, 3.55–8.93; 1.15, 1.11–1.19; and 2.11, 1.4–3.19, respectively) beside the presence of HCC (4.89, 2.48–9.64). Mortality predictors were packed red blood cells units transfused (1.11, 1.01–1.24), CP (5.1, 1.42–18.25) MELD (1.27, 1.21–1.32) scores, and presence of HCC (6.62, 2.93–14.95).
Conclusion
High CP, MELD, and ALBI scores beside the presence of HCC could predict poor outcome of UGIB. In the absence of these risk factors, early discharge could be considered if the source of bleeding is peptic ulcer or telangiectasia. |
doi_str_mv | 10.1111/jgh.14659 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2202196487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2202196487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3259-1ae3a3760049aac8532045453b9f0856466d06021b3308f9fcba9f8174ef9acb3</originalsourceid><addsrcrecordid>eNp1kM9OxCAQh4nR6Prn4AsYjnroLhRoizdj1NWY6ME9N5TSFtNCBRqzNx_BZ_RJRFe9OZdJJt_8MvMBcIzRHMdaPLfdHNOM8S0ww5SiBOc02wYzVGCWcIL5Htj3_hkhRFHOdsEeQZzknLMZWK_GUTnYCh-c1SYoH7QRPax6pWptWqgNvGrXY9DCwFEErUzw8FWHDkrtXGe99ufw0frw8fYeOuXEqKagJbRTkHZQUJgajs62JiJxrE2tpQjW-UOw04jeq6OffgBW11dPl8vk_uHm9vLiPpEkZTzBQhFB8izezoWQBSMpoowyUvEGFSyjWVajDKW4IgQVDW9kJXhTRAOq4UJW5ACcbnLjFS9T_K8ctJeq74VRdvJlmsZlntEij-jZBpXOeu9UU45OD8KtS4zKL9NlNF1-m47syU_sVA2q_iN_1UZgsQFeda_W_yeVdzfLTeQnq3iLRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2202196487</pqid></control><display><type>article</type><title>Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Fouad, Tamer R ; Abdelsameea, Eman ; Abdel‐Razek, Wael ; Attia, Ahmed ; Mohamed, Anwar ; Metwally, Khaled ; Naguib, Mary ; Waked, Imam</creator><creatorcontrib>Fouad, Tamer R ; Abdelsameea, Eman ; Abdel‐Razek, Wael ; Attia, Ahmed ; Mohamed, Anwar ; Metwally, Khaled ; Naguib, Mary ; Waked, Imam</creatorcontrib><description>Background and Aim
Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack.
Methods
A total of 1097 UGIB attacks in 690 patients with liver cirrhosis were studied. Their clinical, laboratory, and endoscopic data were reviewed.
Results
Mean age 53.2 ± 10.6 (20–90) years, 78% men and the main cause of liver disease was hepatitis C (94.9%). Complications occurred after 467 attacks (42.6%): hepatic encephalopathy 31.4%, spontaneous bacterial peritonitis 18%, renal impairment 13.2%, and re‐bleeding in 7.8%, while 199 patients (18.1%) died. Complications followed 78.4% of bleeding from gastric varices, 75% of post‐interventional ulcers, 10.8% of peptic ulcers, and 5.9% of telangiectasias. By univariate analysis: packed red blood cells units transfused, transaminases, Child–Pugh (CP), model of end‐stage liver disease (MELD), and albumin–bilirubin (ALBI) scores, beside the presence of hepatocellular carcinoma (HCC), previous hemorrhage in the previous 6 months, and the source of bleeding, were associated with occurrence of complications. By multivariate analysis, independent predictors of complications were CP, MELD, and ALBI scores (odds ratio, 95% confidence interval: 5.63, 3.55–8.93; 1.15, 1.11–1.19; and 2.11, 1.4–3.19, respectively) beside the presence of HCC (4.89, 2.48–9.64). Mortality predictors were packed red blood cells units transfused (1.11, 1.01–1.24), CP (5.1, 1.42–18.25) MELD (1.27, 1.21–1.32) scores, and presence of HCC (6.62, 2.93–14.95).
Conclusion
High CP, MELD, and ALBI scores beside the presence of HCC could predict poor outcome of UGIB. In the absence of these risk factors, early discharge could be considered if the source of bleeding is peptic ulcer or telangiectasia.</description><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1111/jgh.14659</identifier><identifier>PMID: 30937995</identifier><language>eng</language><publisher>Australia</publisher><subject>Adult ; Aged ; Aged, 80 and over ; ALBI score ; cirrhosis ; Disease Progression ; Egypt - epidemiology ; Esophageal and Gastric Varices - diagnosis ; Esophageal and Gastric Varices - epidemiology ; Esophageal and Gastric Varices - mortality ; Esophageal and Gastric Varices - therapy ; Female ; Gastrointestinal Hemorrhage - diagnosis ; Gastrointestinal Hemorrhage - epidemiology ; Gastrointestinal Hemorrhage - mortality ; Gastrointestinal Hemorrhage - therapy ; Hemostatic Techniques ; Humans ; Hypertension, Portal - diagnosis ; Hypertension, Portal - epidemiology ; Hypertension, Portal - mortality ; Hypertension, Portal - therapy ; Length of Stay ; Liver Cirrhosis - diagnosis ; Liver Cirrhosis - epidemiology ; Liver Cirrhosis - mortality ; Liver Cirrhosis - therapy ; Male ; MELD ; Middle Aged ; Patient Discharge ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome ; upper gastrointestinal bleeding ; Young Adult</subject><ispartof>Journal of gastroenterology and hepatology, 2019-09, Vol.34 (9), p.1604-1610</ispartof><rights>2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd</rights><rights>2019 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3259-1ae3a3760049aac8532045453b9f0856466d06021b3308f9fcba9f8174ef9acb3</citedby><cites>FETCH-LOGICAL-c3259-1ae3a3760049aac8532045453b9f0856466d06021b3308f9fcba9f8174ef9acb3</cites><orcidid>0000-0002-1542-0265 ; 0000-0003-1286-7616</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjgh.14659$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjgh.14659$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30937995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fouad, Tamer R</creatorcontrib><creatorcontrib>Abdelsameea, Eman</creatorcontrib><creatorcontrib>Abdel‐Razek, Wael</creatorcontrib><creatorcontrib>Attia, Ahmed</creatorcontrib><creatorcontrib>Mohamed, Anwar</creatorcontrib><creatorcontrib>Metwally, Khaled</creatorcontrib><creatorcontrib>Naguib, Mary</creatorcontrib><creatorcontrib>Waked, Imam</creatorcontrib><title>Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators</title><title>Journal of gastroenterology and hepatology</title><addtitle>J Gastroenterol Hepatol</addtitle><description>Background and Aim
Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack.
Methods
A total of 1097 UGIB attacks in 690 patients with liver cirrhosis were studied. Their clinical, laboratory, and endoscopic data were reviewed.
Results
Mean age 53.2 ± 10.6 (20–90) years, 78% men and the main cause of liver disease was hepatitis C (94.9%). Complications occurred after 467 attacks (42.6%): hepatic encephalopathy 31.4%, spontaneous bacterial peritonitis 18%, renal impairment 13.2%, and re‐bleeding in 7.8%, while 199 patients (18.1%) died. Complications followed 78.4% of bleeding from gastric varices, 75% of post‐interventional ulcers, 10.8% of peptic ulcers, and 5.9% of telangiectasias. By univariate analysis: packed red blood cells units transfused, transaminases, Child–Pugh (CP), model of end‐stage liver disease (MELD), and albumin–bilirubin (ALBI) scores, beside the presence of hepatocellular carcinoma (HCC), previous hemorrhage in the previous 6 months, and the source of bleeding, were associated with occurrence of complications. By multivariate analysis, independent predictors of complications were CP, MELD, and ALBI scores (odds ratio, 95% confidence interval: 5.63, 3.55–8.93; 1.15, 1.11–1.19; and 2.11, 1.4–3.19, respectively) beside the presence of HCC (4.89, 2.48–9.64). Mortality predictors were packed red blood cells units transfused (1.11, 1.01–1.24), CP (5.1, 1.42–18.25) MELD (1.27, 1.21–1.32) scores, and presence of HCC (6.62, 2.93–14.95).
Conclusion
High CP, MELD, and ALBI scores beside the presence of HCC could predict poor outcome of UGIB. In the absence of these risk factors, early discharge could be considered if the source of bleeding is peptic ulcer or telangiectasia.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>ALBI score</subject><subject>cirrhosis</subject><subject>Disease Progression</subject><subject>Egypt - epidemiology</subject><subject>Esophageal and Gastric Varices - diagnosis</subject><subject>Esophageal and Gastric Varices - epidemiology</subject><subject>Esophageal and Gastric Varices - mortality</subject><subject>Esophageal and Gastric Varices - therapy</subject><subject>Female</subject><subject>Gastrointestinal Hemorrhage - diagnosis</subject><subject>Gastrointestinal Hemorrhage - epidemiology</subject><subject>Gastrointestinal Hemorrhage - mortality</subject><subject>Gastrointestinal Hemorrhage - therapy</subject><subject>Hemostatic Techniques</subject><subject>Humans</subject><subject>Hypertension, Portal - diagnosis</subject><subject>Hypertension, Portal - epidemiology</subject><subject>Hypertension, Portal - mortality</subject><subject>Hypertension, Portal - therapy</subject><subject>Length of Stay</subject><subject>Liver Cirrhosis - diagnosis</subject><subject>Liver Cirrhosis - epidemiology</subject><subject>Liver Cirrhosis - mortality</subject><subject>Liver Cirrhosis - therapy</subject><subject>Male</subject><subject>MELD</subject><subject>Middle Aged</subject><subject>Patient Discharge</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>upper gastrointestinal bleeding</subject><subject>Young Adult</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9OxCAQh4nR6Prn4AsYjnroLhRoizdj1NWY6ME9N5TSFtNCBRqzNx_BZ_RJRFe9OZdJJt_8MvMBcIzRHMdaPLfdHNOM8S0ww5SiBOc02wYzVGCWcIL5Htj3_hkhRFHOdsEeQZzknLMZWK_GUTnYCh-c1SYoH7QRPax6pWptWqgNvGrXY9DCwFEErUzw8FWHDkrtXGe99ufw0frw8fYeOuXEqKagJbRTkHZQUJgajs62JiJxrE2tpQjW-UOw04jeq6OffgBW11dPl8vk_uHm9vLiPpEkZTzBQhFB8izezoWQBSMpoowyUvEGFSyjWVajDKW4IgQVDW9kJXhTRAOq4UJW5ACcbnLjFS9T_K8ctJeq74VRdvJlmsZlntEij-jZBpXOeu9UU45OD8KtS4zKL9NlNF1-m47syU_sVA2q_iN_1UZgsQFeda_W_yeVdzfLTeQnq3iLRA</recordid><startdate>201909</startdate><enddate>201909</enddate><creator>Fouad, Tamer R</creator><creator>Abdelsameea, Eman</creator><creator>Abdel‐Razek, Wael</creator><creator>Attia, Ahmed</creator><creator>Mohamed, Anwar</creator><creator>Metwally, Khaled</creator><creator>Naguib, Mary</creator><creator>Waked, Imam</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1542-0265</orcidid><orcidid>https://orcid.org/0000-0003-1286-7616</orcidid></search><sort><creationdate>201909</creationdate><title>Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators</title><author>Fouad, Tamer R ; Abdelsameea, Eman ; Abdel‐Razek, Wael ; Attia, Ahmed ; Mohamed, Anwar ; Metwally, Khaled ; Naguib, Mary ; Waked, Imam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3259-1ae3a3760049aac8532045453b9f0856466d06021b3308f9fcba9f8174ef9acb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>ALBI score</topic><topic>cirrhosis</topic><topic>Disease Progression</topic><topic>Egypt - epidemiology</topic><topic>Esophageal and Gastric Varices - diagnosis</topic><topic>Esophageal and Gastric Varices - epidemiology</topic><topic>Esophageal and Gastric Varices - mortality</topic><topic>Esophageal and Gastric Varices - therapy</topic><topic>Female</topic><topic>Gastrointestinal Hemorrhage - diagnosis</topic><topic>Gastrointestinal Hemorrhage - epidemiology</topic><topic>Gastrointestinal Hemorrhage - mortality</topic><topic>Gastrointestinal Hemorrhage - therapy</topic><topic>Hemostatic Techniques</topic><topic>Humans</topic><topic>Hypertension, Portal - diagnosis</topic><topic>Hypertension, Portal - epidemiology</topic><topic>Hypertension, Portal - mortality</topic><topic>Hypertension, Portal - therapy</topic><topic>Length of Stay</topic><topic>Liver Cirrhosis - diagnosis</topic><topic>Liver Cirrhosis - epidemiology</topic><topic>Liver Cirrhosis - mortality</topic><topic>Liver Cirrhosis - therapy</topic><topic>Male</topic><topic>MELD</topic><topic>Middle Aged</topic><topic>Patient Discharge</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>upper gastrointestinal bleeding</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fouad, Tamer R</creatorcontrib><creatorcontrib>Abdelsameea, Eman</creatorcontrib><creatorcontrib>Abdel‐Razek, Wael</creatorcontrib><creatorcontrib>Attia, Ahmed</creatorcontrib><creatorcontrib>Mohamed, Anwar</creatorcontrib><creatorcontrib>Metwally, Khaled</creatorcontrib><creatorcontrib>Naguib, Mary</creatorcontrib><creatorcontrib>Waked, Imam</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fouad, Tamer R</au><au>Abdelsameea, Eman</au><au>Abdel‐Razek, Wael</au><au>Attia, Ahmed</au><au>Mohamed, Anwar</au><au>Metwally, Khaled</au><au>Naguib, Mary</au><au>Waked, Imam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2019-09</date><risdate>2019</risdate><volume>34</volume><issue>9</issue><spage>1604</spage><epage>1610</epage><pages>1604-1610</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><abstract>Background and Aim
Upper gastrointestinal bleeding (UGIB) is a serious complication of portal hypertension in cirrhotic patients. The objective of this study is to identify the risk factors for morbidity and mortality occurring after an UGIB attack.
Methods
A total of 1097 UGIB attacks in 690 patients with liver cirrhosis were studied. Their clinical, laboratory, and endoscopic data were reviewed.
Results
Mean age 53.2 ± 10.6 (20–90) years, 78% men and the main cause of liver disease was hepatitis C (94.9%). Complications occurred after 467 attacks (42.6%): hepatic encephalopathy 31.4%, spontaneous bacterial peritonitis 18%, renal impairment 13.2%, and re‐bleeding in 7.8%, while 199 patients (18.1%) died. Complications followed 78.4% of bleeding from gastric varices, 75% of post‐interventional ulcers, 10.8% of peptic ulcers, and 5.9% of telangiectasias. By univariate analysis: packed red blood cells units transfused, transaminases, Child–Pugh (CP), model of end‐stage liver disease (MELD), and albumin–bilirubin (ALBI) scores, beside the presence of hepatocellular carcinoma (HCC), previous hemorrhage in the previous 6 months, and the source of bleeding, were associated with occurrence of complications. By multivariate analysis, independent predictors of complications were CP, MELD, and ALBI scores (odds ratio, 95% confidence interval: 5.63, 3.55–8.93; 1.15, 1.11–1.19; and 2.11, 1.4–3.19, respectively) beside the presence of HCC (4.89, 2.48–9.64). Mortality predictors were packed red blood cells units transfused (1.11, 1.01–1.24), CP (5.1, 1.42–18.25) MELD (1.27, 1.21–1.32) scores, and presence of HCC (6.62, 2.93–14.95).
Conclusion
High CP, MELD, and ALBI scores beside the presence of HCC could predict poor outcome of UGIB. In the absence of these risk factors, early discharge could be considered if the source of bleeding is peptic ulcer or telangiectasia.</abstract><cop>Australia</cop><pmid>30937995</pmid><doi>10.1111/jgh.14659</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-1542-0265</orcidid><orcidid>https://orcid.org/0000-0003-1286-7616</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0815-9319 |
ispartof | Journal of gastroenterology and hepatology, 2019-09, Vol.34 (9), p.1604-1610 |
issn | 0815-9319 1440-1746 |
language | eng |
recordid | cdi_proquest_miscellaneous_2202196487 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult Aged Aged, 80 and over ALBI score cirrhosis Disease Progression Egypt - epidemiology Esophageal and Gastric Varices - diagnosis Esophageal and Gastric Varices - epidemiology Esophageal and Gastric Varices - mortality Esophageal and Gastric Varices - therapy Female Gastrointestinal Hemorrhage - diagnosis Gastrointestinal Hemorrhage - epidemiology Gastrointestinal Hemorrhage - mortality Gastrointestinal Hemorrhage - therapy Hemostatic Techniques Humans Hypertension, Portal - diagnosis Hypertension, Portal - epidemiology Hypertension, Portal - mortality Hypertension, Portal - therapy Length of Stay Liver Cirrhosis - diagnosis Liver Cirrhosis - epidemiology Liver Cirrhosis - mortality Liver Cirrhosis - therapy Male MELD Middle Aged Patient Discharge Retrospective Studies Risk Factors Time Factors Treatment Outcome upper gastrointestinal bleeding Young Adult |
title | Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post‐therapeutic outcome and prognostic indicators |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A24%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upper%20gastrointestinal%20bleeding%20in%20Egyptian%20patients%20with%20cirrhosis:%20Post%E2%80%90therapeutic%20outcome%20and%20prognostic%20indicators&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=Fouad,%20Tamer%20R&rft.date=2019-09&rft.volume=34&rft.issue=9&rft.spage=1604&rft.epage=1610&rft.pages=1604-1610&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1111/jgh.14659&rft_dat=%3Cproquest_cross%3E2202196487%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2202196487&rft_id=info:pmid/30937995&rfr_iscdi=true |